These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32610107)

  • 1. Investigation of a family outbreak of COVID-19 using systematic rapid diagnostic tests raises new questions about transmission.
    Prazuck T; Giaché S; Gubavu C; Colin M; Rzepecki V; Sève A; Pialoux G; Hocqueloux L
    J Infect; 2020 Oct; 81(4):647-679. PubMed ID: 32610107
    [No Abstract]   [Full Text] [Related]  

  • 2. What Is the Role of Severe Acute Respiratory Syndrome Coronavirus 2 Polymerase Chain Reaction Testing in Discontinuation of Transmission-based Precautions for Coronavirus Disease 2019 Patients?
    Abu Raya B; Goldfarb DM; Sadarangani M
    Clin Infect Dis; 2020 Nov; 71(16):2304-2305. PubMed ID: 32472672
    [No Abstract]   [Full Text] [Related]  

  • 3. Special Issue on Diagnostic Testing for Severe Acute Respiratory Syndrome Coronavirus 2 and Lessons from This Pandemic.
    McAdam AJ
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32703896
    [No Abstract]   [Full Text] [Related]  

  • 4. Characteristics of recovered COVID-19 patients with recurrent positive RT-PCR findings in Wuhan, China: a retrospective study.
    Shui TJ; Li C; Liu HB; Chen X; Zhang BK
    BMC Infect Dis; 2020 Oct; 20(1):749. PubMed ID: 33050892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 diagnostic testing in Africa: needs and challenges.
    Adebisi YA; Oke GI; Ademola PS; Chinemelum IG; Ogunkola IO; Lucero-Prisno Iii DE
    Pan Afr Med J; 2020; 35(Suppl 2):4. PubMed ID: 32528615
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe Acute Respiratory Syndrome Coronavirus 2 among Asymptomatic Workers Screened for Work Resumption, China.
    Han X; Wei X; Alwalid O; Cao Y; Li Y; Wang L; Shi H
    Emerg Infect Dis; 2020 Sep; 26(9):2265-7. PubMed ID: 32553070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [COVID-19 and Pulmonology: New Challenges and Opportunities].
    Clérigo V; Duarte P
    Acta Med Port; 2020 Oct; 33(10):710. PubMed ID: 32877327
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of Three Commercial Automated Assays for the Detection of Anti-SARS-CoV-2 Antibodies.
    Harb R; Remaley AT; Sacks DB
    Clin Chem; 2020 Oct; 66(10):1351-1353. PubMed ID: 32761081
    [No Abstract]   [Full Text] [Related]  

  • 9. Another false-positive problem for a SARS-CoV-2 antigen test in Japan.
    Ogawa T; Fukumori T; Nishihara Y; Sekine T; Okuda N; Nishimura T; Fujikura H; Hirai N; Imakita N; Kasahara K
    J Clin Virol; 2020 Oct; 131():104612. PubMed ID: 32871543
    [No Abstract]   [Full Text] [Related]  

  • 10. Salient lessons from Russia's COVID-19 outbreak.
    The Lancet
    Lancet; 2020 Jun; 395(10239):1739. PubMed ID: 32505241
    [No Abstract]   [Full Text] [Related]  

  • 11. Possible Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a Public Bath Center in Huai'an, Jiangsu Province, China.
    Luo C; Yao L; Zhang L; Yao M; Chen X; Wang Q; Shen H
    JAMA Netw Open; 2020 Mar; 3(3):e204583. PubMed ID: 32227177
    [No Abstract]   [Full Text] [Related]  

  • 12. Serological tests for COVID-19.
    Bond K; Williams E; Howden BP; Williamson DA
    Med J Aust; 2020 Nov; 213(9):397-399.e1. PubMed ID: 32892381
    [No Abstract]   [Full Text] [Related]  

  • 13. Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives.
    Infantino M; Damiani A; Gobbi FL; Grossi V; Lari B; Macchia D; Casprini P; Veneziani F; Villalta D; Bizzaro N; Cappelletti P; Fabris M; Quartuccio L; Benucci M; Manfredi M
    Isr Med Assoc J; 2020 Apr; 22(4):203-210. PubMed ID: 32286019
    [No Abstract]   [Full Text] [Related]  

  • 14. Laboratory diagnosis for Covid-19: A mini-review.
    Pizzol JLD; Hora VPD; Reis AJ; Vianna J; Ramis I; Groll AV; Silva PAD
    Rev Soc Bras Med Trop; 2020; 53():e20200451. PubMed ID: 32876316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing animals for SARS-CoV-2.
    Middlemiss C; Glossop C; Voas S; Huey R
    Vet Rec; 2020 May; 186(17):571-572. PubMed ID: 32482825
    [No Abstract]   [Full Text] [Related]  

  • 16. University participation in the production of molecular diagnostic tests for the novel coronavirus in Brazil: the response to health challenges.
    Silva RGLD; Chammas R; Plonski GA; Goldbaum M; Ferreira LCS; Novaes HMD
    Cad Saude Publica; 2020; 36(6):e00115520. PubMed ID: 32609169
    [No Abstract]   [Full Text] [Related]  

  • 17. Two Pandemics, One Challenge-Leveraging Molecular Test Capacity of Tuberculosis Laboratories for Rapid COVID-19 Case-Finding.
    Homolka S; Paulowski L; Andres S; Hillemann D; Jou R; Günther G; Claassens M; Kuhns M; Niemann S; Maurer FP
    Emerg Infect Dis; 2020 Nov; 26(11):2549-2554. PubMed ID: 32956612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urticaria in a patient with COVID-19: Therapeutic and diagnostic difficulties.
    Aktaş H; Hamidi AA
    Dermatol Ther; 2020 Jul; 33(4):e13610. PubMed ID: 32418320
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination of RT-qPCR testing and clinical features for diagnosis of COVID-19 facilitates management of SARS-CoV-2 outbreak.
    Wang Y; Kang H; Liu X; Tong Z
    J Med Virol; 2020 Jun; 92(6):538-539. PubMed ID: 32096564
    [No Abstract]   [Full Text] [Related]  

  • 20. Accuracy of the Polymerase Chain Reaction (PCR) test in the diagnosis of acute respiratory syndrome due to coronavirus: a systematic review and meta-analysis.
    Floriano I; Silvinato A; Bernardo WM; Reis JC; Soledade G
    Rev Assoc Med Bras (1992); 2020 Jul; 66(7):880-888. PubMed ID: 32844930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.